<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>isoniazid</title><link>http://www.unboundmedicine.com/medline/ebm/research/isoniazid</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Update on Tuberculosis of the Central Nervous System: Pathogenesis, Diagnosis, and Treatment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925964/full_citation/Update_on_Tuberculosis_of_the_Central_Nervous_System:_Pathogenesis_Diagnosis_and_Treatment_</link><description>Thwaites GE, Schoeman JF <br/><span class="title">Update on Tuberculosis of the Central Nervous System: Pathogenesis, Diagnosis, and Treatment. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinics in chest medicine">Clin Chest Med 2009 Dec; 30(4):745-754.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925964/abstract/Update_on_Tuberculosis_of_the_Central_Nervous_System:_Pathogenesis_Diagnosis_and_Treatment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925964/full_citation/Update_on_Tuberculosis_of_the_Central_Nervous_System:_Pathogenesis_Diagnosis_and_Treatment_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19925964/Update_on_Tuberculosis_of_the_Central_Nervous_System:_Pathogenesis_Diagnosis_and_Treatment_">Find Related Articles</a> </description></item><item><title>Investigating Biological Activity Spectrum for Novel Styrylquinazoline Analogues.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19924061/full_citation/Investigating_Biological_Activity_Spectrum_for_Novel_Styrylquinazoline_Analogues_</link><description>Jampilek J, Musiol R, Finster J, et al. <br/><span class="title">Investigating Biological Activity Spectrum for Novel Styrylquinazoline Analogues. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecules (Basel, Switzerland)">Molecules 2009; 14(10):4246-4265.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19924061/abstract/Investigating_Biological_Activity_Spectrum_for_Novel_Styrylquinazoline_Analogues_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19924061/full_citation/Investigating_Biological_Activity_Spectrum_for_Novel_Styrylquinazoline_Analogues_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19924061/Investigating_Biological_Activity_Spectrum_for_Novel_Styrylquinazoline_Analogues_">Find Related Articles</a> </description></item><item><title>Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to anti-tuberculosis therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923475/full_citation/Sputum_Mycobacterium_tuberculosis_mRNA_as_a_marker_of_bacteriologic_clearance_in_response_to_anti_tuberculosis_therapy_</link><description>Li L, Mahan CS, Palaci M, et al. <br/><span class="title">Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to anti-tuberculosis therapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical microbiology">J Clin Microbiol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923475/abstract/Sputum_Mycobacterium_tuberculosis_mRNA_as_a_marker_of_bacteriologic_clearance_in_response_to_anti_tuberculosis_therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923475/full_citation/Sputum_Mycobacterium_tuberculosis_mRNA_as_a_marker_of_bacteriologic_clearance_in_response_to_anti_tuberculosis_therapy_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923475/Sputum_Mycobacterium_tuberculosis_mRNA_as_a_marker_of_bacteriologic_clearance_in_response_to_anti_tuberculosis_therapy_">Find Related Articles</a> </description></item><item><title>Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920896/full_citation/Changes_in_CD4+_T_cells_and_HIV_RNA_resulting_from_combination_of_anti_TB_therapy_with_Dzherelo_in_TB/HIV_dually_infected_patients_</link><description>Nikolaeva LG, Maystat TV, Masyuk LA, et al. <br/><span class="title">Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Drug design, development and therapy">Drug Des Devel Ther 2009.:87-93.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920896/abstract/Changes_in_CD4+_T_cells_and_HIV_RNA_resulting_from_combination_of_anti_TB_therapy_with_Dzherelo_in_TB/HIV_dually_infected_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920896/full_citation/Changes_in_CD4+_T_cells_and_HIV_RNA_resulting_from_combination_of_anti_TB_therapy_with_Dzherelo_in_TB/HIV_dually_infected_patients_">Full Citation</a></description></item><item><title>Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19919774/full_citation/Evaluation_of_the_nitrate_reductase_assay_for_rapid_detection_of_extensively_drug_resistant_tuberculosis_</link><description>Rosales S, Pineda-García L, Andino N, et al. <br/><span class="title">Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis. [JOURNAL ARTICLE]</span><br/><span class="source" title="The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease">Int J Tuberc Lung Dis 2009 Dec; 13(12):1542-1549.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19919774/abstract/Evaluation_of_the_nitrate_reductase_assay_for_rapid_detection_of_extensively_drug_resistant_tuberculosis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19919774/full_citation/Evaluation_of_the_nitrate_reductase_assay_for_rapid_detection_of_extensively_drug_resistant_tuberculosis_">Full Citation</a></description></item><item><title>Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19919768/full_citation/Contact_screening_and_chemoprophylaxis_in_India's_Revised_Tuberculosis_Control_Programme:_a_situational_analysis_</link><description>Banu Rekha VV, Jagarajamma K, Wares F, et al. <br/><span class="title">Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis. [JOURNAL ARTICLE]</span><br/><span class="source" title="The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease">Int J Tuberc Lung Dis 2009 Dec; 13(12):1507-1512.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19919768/abstract/Contact_screening_and_chemoprophylaxis_in_India's_Revised_Tuberculosis_Control_Programme:_a_situational_analysis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19919768/full_citation/Contact_screening_and_chemoprophylaxis_in_India's_Revised_Tuberculosis_Control_Programme:_a_situational_analysis_">Full Citation</a></description></item><item><title>Successful liver transplantation in antituberculosis therapy-induced acute fulminant hepatic failure.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917416/full_citation/Successful_liver_transplantation_in_antituberculosis_therapy_induced_acute_fulminant_hepatic_failure_</link><description>Schneider R, Bercker S, Schubert S, et al. <br/><span class="title">Successful liver transplantation in antituberculosis therapy-induced acute fulminant hepatic failure. [Journal Article]</span><br/><span class="source" title="Transplantation proceedings">Transplant Proc 2009 Nov; 41(9):3934-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917416/abstract/Successful_liver_transplantation_in_antituberculosis_therapy_induced_acute_fulminant_hepatic_failure_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917416/full_citation/Successful_liver_transplantation_in_antituberculosis_therapy_induced_acute_fulminant_hepatic_failure_">Full Citation</a></description></item><item><title>4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta-analysis and Cost-Effectiveness Study That Focuses on Compliance and Liver Toxicity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19911936/full_citation/4_Months_of_Rifampin_Compared_with_9_Months_of_Isoniazid_for_the_Management_of_Latent_Tuberculosis_Infection:_A_Meta_analysis_and_Cost_Effectiveness_Study_That_Focuses_on_Compliance_and_Liver_Toxicity_</link><description>Ziakas PD, Mylonakis E <br/><span class="title">4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta-analysis and Cost-Effectiveness Study That Focuses on Compliance and Liver Toxicity. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America">Clin Infect Dis 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19911936/abstract/4_Months_of_Rifampin_Compared_with_9_Months_of_Isoniazid_for_the_Management_of_Latent_Tuberculosis_Infection:_A_Meta_analysis_and_Cost_Effectiveness_Study_That_Focuses_on_Compliance_and_Liver_Toxicity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19911936/full_citation/4_Months_of_Rifampin_Compared_with_9_Months_of_Isoniazid_for_the_Management_of_Latent_Tuberculosis_Infection:_A_Meta_analysis_and_Cost_Effectiveness_Study_That_Focuses_on_Compliance_and_Liver_Toxicity_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19911936/4_Months_of_Rifampin_Compared_with_9_Months_of_Isoniazid_for_the_Management_of_Latent_Tuberculosis_Infection:_A_Meta_analysis_and_Cost_Effectiveness_Study_That_Focuses_on_Compliance_and_Liver_Toxicity_">Find Related Articles</a> </description></item><item><title>Mode of binding of the tuberculosis prodrug isoniazid to heme peroxidases: Binding studies and crystal structure of bovine lactoperoxidase with isoniazid at 2.7 angstrom resolution.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907057/full_citation/Mode_of_binding_of_the_tuberculosis_prodrug_isoniazid_to_heme_peroxidases:_Binding_studies_and_crystal_structure_of_bovine_lactoperoxidase_with_isoniazid_at_2_7_angstrom_resolution_</link><description>Singh AK, Kumar RP, Pandey N, et al. <br/><span class="title">Mode of binding of the tuberculosis prodrug isoniazid to heme peroxidases: Binding studies and crystal structure of bovine lactoperoxidase with isoniazid at 2.7 angstrom resolution. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of biological chemistry">J Biol Chem 2009 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907057/abstract/Mode_of_binding_of_the_tuberculosis_prodrug_isoniazid_to_heme_peroxidases:_Binding_studies_and_crystal_structure_of_bovine_lactoperoxidase_with_isoniazid_at_2_7_angstrom_resolution_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907057/full_citation/Mode_of_binding_of_the_tuberculosis_prodrug_isoniazid_to_heme_peroxidases:_Binding_studies_and_crystal_structure_of_bovine_lactoperoxidase_with_isoniazid_at_2_7_angstrom_resolution_">Full Citation</a> | <a href="http://www.jbc.org/cgi/pmidlookup%3fview=long%26amp;pmid=19907057">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19907057/Mode_of_binding_of_the_tuberculosis_prodrug_isoniazid_to_heme_peroxidases:_Binding_studies_and_crystal_structure_of_bovine_lactoperoxidase_with_isoniazid_at_2_7_angstrom_resolution_">Find Related Articles</a> </description></item><item><title>In situ, real-time tracking of cell wall topography and nanomechanics of antimycobacterial drugs treated Mycobacterium JLS using atomic force microscopy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19904381/full_citation/In_situ_real_time_tracking_of_cell_wall_topography_and_nanomechanics_of_antimycobacterial_drugs_treated_Mycobacterium_JLS_using_atomic_force_microscopy_</link><description>Wu Y, Zhou A <br/><span class="title">In situ, real-time tracking of cell wall topography and nanomechanics of antimycobacterial drugs treated Mycobacterium JLS using atomic force microscopy. [JOURNAL ARTICLE]</span><br/><span class="source" title="Chemical communications (Cambridge, England)">Chem Commun (Camb) 2009 Dec 7; (45):7021-7023.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19904381/abstract/In_situ_real_time_tracking_of_cell_wall_topography_and_nanomechanics_of_antimycobacterial_drugs_treated_Mycobacterium_JLS_using_atomic_force_microscopy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19904381/full_citation/In_situ_real_time_tracking_of_cell_wall_topography_and_nanomechanics_of_antimycobacterial_drugs_treated_Mycobacterium_JLS_using_atomic_force_microscopy_">Full Citation</a></description></item></channel></rss>